Last reviewed: September 1, 2026 Last updated: September 1, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Embody's month-to-month rate for compounded semaglutide injection is $299; tirzepatide injection costs $349/month (verified July 21, 2026). PlexusDx charges $189/month for semaglutide injection and $289/month for tirzepatide injection on equivalent month-to-month terms, a difference of $1,320 and $720 annually. Embody offers a six-month money-back guarantee and 24/7 clinical chat support; PlexusDx offers genetic testing for medication response, a named clinical pharmacist (Dr. Jayden Lee, PharmD), and four medication formats including oral capsules and a microdose option. Both programs ship medication directly, include unlimited provider visits, and permit cancellation anytime on monthly plans. Neither charges until a provider approves the prescription. The choice turns on whether you value Embody's guarantee and round-the-clock chat access or PlexusDx's lower base pricing, format diversity, and genetics layer.

Deciding between injectable-only programs and multi-format options?

Compare route, pricing, and clinical support across PlexusDx's full weight-management lineup.

Explore All Options →

At-a-glance comparison

Feature Embody PlexusDx
Semaglutide injection (MTM) $299/month $189/month
Tirzepatide injection (MTM) $349/month $289/month
Oral formats Not offered Semaglutide $289/mo, Tirzepatide $349/mo
Microdose option Not offered $129/month
Prepaid multi-month Available (rates not published) 3-mo and 6-mo tiers at lower rates
Provider visits Unlimited Unlimited
Clinical support model 24/7 clinical chat Named PharmD (Dr. Jayden Lee), free one-on-one check-in
Money-back guarantee 6 months None
Genetic testing for medication response Not offered $99 for members ($298 standalone)
Cancellation Anytime (monthly plan) Anytime (monthly plan)
Membership fee None None

All pricing verified July 17–23, 2026. Embody figures from embody.com July 21; PlexusDx figures from plexusdx.com July 17–23. MTM = month-to-month.

Like-for-like pricing and 12-month cost

Month-to-month plans represent the cleanest comparison because both programs publish standard ongoing rates at this tier and permit cancellation anytime. Over twelve months on a month-to-month basis:

  • Semaglutide injection: Embody $299/month × 12 = $3,588/year; PlexusDx $189/month × 12 = $2,268/year. PlexusDx is $1,320 lower annually (our calculation).
  • Tirzepatide injection: Embody $349/month × 12 = $4,188/year; PlexusDx $289/month × 12 = $3,468/year. PlexusDx is $720 lower annually (our calculation).

Embody offers multi-month prepaid tiers, but rates were not published in available sources as of July 21, 2026; no like-for-like comparison with PlexusDx's prepaid tiers is possible under our methodology. PlexusDx's three-month rate for semaglutide injection is $169/month; the six-month rate is $149/month. Tirzepatide injection costs $269/month on a three-month plan and $249/month on a six-month plan. These are labeled as prepaid per-month equivalents and represent our calculation for annual cost: semaglutide six-month total over twelve months is $1,788/year; tirzepatide six-month total over twelve months is $2,988/year.

Both programs include provider visits, prescription review, medication, and shipping in the listed price. Neither charges a membership fee. Neither charges until a provider approves the prescription and dose.

PlexusDx semaglutide injection is $189/month with no membership fee

A licensed provider reviews your intake and confirms fit before any charge posts.

Start My 60-Second Intake →

About 60 seconds · $0 charged until provider approval.

Medication format and route options

Embody offers compounded semaglutide and tirzepatide by injection only, as verified on July 21, 2026. No oral formats or microdose protocols were listed. PlexusDx offers four formats: semaglutide injection ($189/month month-to-month), tirzepatide injection ($289/month), semaglutide oral capsules ($289/month), tirzepatide oral capsules ($349/month), and a microdose GLP-1 injection ($129/month). The microdose option may suit individuals seeking a lower-intensity protocol or transitioning off standard-dose therapy; a licensed clinician determines whether any format is appropriate for an individual patient.

If you are certain you prefer injection and have no interest in oral alternatives or microdose, Embody's format constraint is immaterial. If you want the option to switch routes without changing providers—for example, moving from injection to oral mid-treatment—PlexusDx's format diversity becomes relevant.

Clinical support and access models

Embody includes 24/7 clinical chat support and unlimited provider visits. The round-the-clock chat access may appeal to individuals who prefer asynchronous text-based contact outside standard business hours or who anticipate questions at unpredictable times.

PlexusDx assigns a named clinical pharmacist—Dr. Jayden Lee, PharmD—and includes a free one-on-one check-in. The named-clinician model provides continuity; the same pharmacist reviews your case over time. Both programs offer unlimited provider visits within their respective structures. Neither model is objectively superior; the choice depends on whether you value immediate text access or longitudinal continuity with a single pharmacist.

Money-back guarantee and financial risk

Embody offers a six-month money-back guarantee. The full terms and conditions of the guarantee were not detailed in the source captured July 21, 2026; confirm eligibility criteria, exclusions, and refund process at checkout. A six-month guarantee may reduce perceived financial risk, particularly for individuals new to GLP-1 therapy who are uncertain whether they will tolerate the medication or achieve meaningful weight loss.

PlexusDx does not offer a money-back guarantee. Both programs charge only after a provider approves the prescription, so the initial intake and provider review carry no financial risk in either case. The difference emerges after treatment begins: Embody permits a refund request within six months; PlexusDx does not.

Genetic testing for medication response

PlexusDx offers optional genetic testing for medication response at $99 for program members or $298 standalone (verified July 21, 2026). The test analyzes genetic markers that may inform medication metabolism and side-effect risk. The test does not select or predict which medication will work; a licensed clinician interprets results and decides whether to adjust treatment. Embody does not offer a genetics layer as of July 2026.

Genetic data may help explain why one individual experiences nausea at a dose another tolerates easily, or why absorption varies. The clinical utility is adjunctive—genetic information complements, but does not replace, symptom monitoring and dose titration. If you are interested in a precision-medicine approach or have a history of atypical medication responses, the genetics option may be worth the $99 add-on cost. If you prefer a simpler protocol without ancillary testing, the absence of a genetics layer at Embody is not a disadvantage.

Choose Embody if…

  • You want a six-month money-back guarantee to limit financial risk during the initial treatment phase.
  • You prefer 24/7 clinical chat access and anticipate needing asynchronous support outside business hours.
  • You are confident you want injectable medication only and have no interest in oral or microdose alternatives.
  • You are comfortable with Embody's month-to-month rate of $299 for semaglutide or $349 for tirzepatide and do not prioritize the lower base pricing available elsewhere.

Choose PlexusDx if…

  • You want the lowest published month-to-month rate for injectable semaglutide ($189) or tirzepatide ($289), saving $1,320 or $720 annually compared to Embody's standard pricing.
  • You value medication-format flexibility and want the option to switch between injection and oral routes, or to explore a microdose protocol, without changing providers.
  • You prefer working with a named clinical pharmacist (Dr. Jayden Lee, PharmD) who reviews your case longitudinally rather than a rotating chat-support team.
  • You are interested in optional genetic testing for medication response ($99 for members) to inform treatment decisions.
  • You do not require a money-back guarantee and are comfortable with the standard pay-as-you-go model that charges only after provider approval each cycle.

Methodology and freshness

All Embody pricing and features were captured from embody.com on July 21, 2026. PlexusDx pricing and features were captured from plexusdx.com between July 17 and July 23, 2026. We publish standard ongoing rates and prepaid totals only, verified at the dates shown. Twelve-month cost calculations and annual savings figures are our calculation, derived by multiplying the verified monthly rate by twelve. Embody's multi-month prepaid rates exist but were not published in available sources; no like-for-like prepaid comparison is possible under our methodology. Confirm all pricing, guarantee terms, and clinical-support details at checkout, as program terms may change after the capture dates cited here.

Frequently Asked Questions

Does Embody offer oral semaglutide or tirzepatide?

No. As of July 21, 2026, Embody offers compounded semaglutide and tirzepatide by injection only. Oral formats were not listed. PlexusDx offers both injectable and oral capsule versions of semaglutide and tirzepatide, as well as a microdose injection option.

What does Embody's six-month money-back guarantee cover?

Embody advertises a six-month money-back guarantee, but the full terms—including eligibility criteria, exclusions, and refund process—were not detailed in the source captured July 21, 2026. Confirm the guarantee conditions at checkout or by contacting Embody directly before starting treatment.

Can I cancel either program anytime?

Yes. Both Embody and PlexusDx permit cancellation anytime on month-to-month plans. Neither charges until a provider approves your prescription each cycle, so you are not billed in advance for future months if you decide to stop treatment.

Does PlexusDx offer 24/7 chat support like Embody?

No. PlexusDx assigns a named clinical pharmacist, Dr. Jayden Lee, PharmD, and includes a free one-on-one check-in, but does not operate a round-the-clock chat service. Embody provides 24/7 clinical chat access. Both programs offer unlimited provider visits within their respective support models.

Is genetic testing for medication response required at PlexusDx?

No. Genetic testing for medication response is optional and costs $99 for program members or $298 standalone. The test does not select or predict which medication will work; a licensed clinician interprets results and decides whether to adjust treatment. Many patients proceed without the test and rely on symptom monitoring and dose titration alone.

Sources

  • Embody pricing, features, and clinical-support model: embody.com, accessed July 21, 2026.
  • PlexusDx pricing, medication formats, and genetic testing details: plexusdx.com, accessed July 17–23, 2026.

Ready to compare your options with a licensed provider?

One all-inclusive price covers your online provider visit, prescription, medication, and shipping — no membership, no hidden fees. Complete a short intake and a licensed provider reviews your fit.

Start My Intake →

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.